Phytoremediation: Molecular biology, requirements for application, environmental protection, public attention and feasibility . Peuke, A., D. EMBO Reports, 6(6):497-501, 2005.
abstract   bibtex   
[Second and third paragraphs] Cleaning up contaminated soil is a costly enterprise—the overall cost to remediate affected sites in the EU is estimated to be between €59 and €109 billion (EC, 2002). Furthermore, current methods of soil remediation do not really solve the problem. In Germany, for instance, only 30% of soils from contaminated sites are cleaned up in soil remediation facilities (SRU, 2004); the remaining soil must be stored in waste disposal facilities. This does not solve the problem, it merely transfers it to future generations. Obviously, there is an urgent need for alternative, cheap and efficient methods to clean up heavily contaminated industrial areas. This could be achieved by a relatively new technology known as phytoremediation, which uses plants to remove pollutants from the environment. Due to its elegance and the extent of contaminated areas, it has already received significant scientific and commercial attention (Salt et al, 1998; Gleba et al, 1999; Meagher, 2000; Dietz & Schnoor, 2001; Guerinot & Salt, 2001; Krämer & Chardonnens, 2001; McGrath & Zhao, 2003; Peuke & Rennenberg, 2005). Phytoremediation uses wild or genetically modified plants (GMPs) to extract a wide range of heavy metals and organic pollutants from the soil. Initial experiments with transgenic plants have shown that they are indeed efficient in drawing metals from heavily contaminated soils. However, despite this and other advantages, the progress and application of this technology to tackle widespread environmental problems is being hampered by ideology-driven, restrictive legislation over the use and release of GMPs in Europe, and particularly in Germany.
@article{
 title = {Phytoremediation:  Molecular biology, requirements for application, environmental protection, public attention and feasibility
},
 type = {article},
 year = {2005},
 pages = {497-501},
 volume = {6},
 chapter = {497},
 id = {a16d56a9-90be-30cb-b383-bf23911cda64},
 created = {2012-01-05T13:08:30.000Z},
 file_attached = {false},
 profile_id = {1a467167-0a41-3583-a6a3-034c31031332},
 group_id = {0e532975-1a47-38a4-ace8-4fe5968bcd72},
 last_modified = {2012-01-05T13:14:47.000Z},
 tags = {environmental,phytoremediation,review},
 read = {false},
 starred = {false},
 authored = {false},
 confirmed = {true},
 hidden = {false},
 source_type = {Journal Article},
 abstract = {[Second and third paragraphs]  Cleaning up contaminated soil is a costly enterprise—the overall cost to remediate affected sites in the EU is estimated to be between €59 and €109 billion (EC, 2002). Furthermore, current methods of soil remediation do not really solve the problem. In Germany, for instance, only 30% of soils from contaminated sites are cleaned up in soil remediation facilities (SRU, 2004); the remaining soil must be stored in waste disposal facilities. This does not solve the problem, it merely transfers it to future generations. Obviously, there is an urgent need for alternative, cheap and efficient methods to clean up heavily contaminated industrial areas. This could be achieved by a relatively new technology known as phytoremediation, which uses plants to remove pollutants from the environment. Due to its elegance and the extent of contaminated areas, it has already received significant scientific and commercial attention (Salt et al, 1998; Gleba et al, 1999; Meagher, 2000; Dietz & Schnoor, 2001; Guerinot & Salt, 2001; Krämer & Chardonnens, 2001; McGrath & Zhao, 2003; Peuke & Rennenberg, 2005). Phytoremediation uses wild or genetically modified plants (GMPs) to extract a wide range of heavy metals and organic pollutants from the soil. Initial experiments with transgenic plants have shown that they are indeed efficient in drawing metals from heavily contaminated soils. However, despite this and other advantages, the progress and application of this technology to tackle widespread environmental problems is being hampered by ideology-driven, restrictive legislation over the use and release of GMPs in Europe, and particularly in Germany.},
 bibtype = {article},
 author = {Peuke, Andreas D},
 journal = {EMBO Reports},
 number = {6}
}

Downloads: 0